26
Participants
Start Date
March 5, 2018
Primary Completion Date
November 4, 2019
Study Completion Date
November 4, 2019
Dapagliflozin
"The study consist of 5 weeks treatment period 1, 6-8 weeks wash-out period and 5 weeks treatment period 2.~The patient will be administered dapagliflozin 10 mg during Period 1 or Period 2."
Research Site, Maastricht
Lead Sponsor
AstraZeneca
INDUSTRY